Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 18, 1988 - Issue 4
79
Views
127
CrossRef citations to date
0
Altmetric
Original Article

The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugs

&
Pages 459-470 | Received 17 Jul 1987, Accepted 19 Nov 1987, Published online: 30 Sep 2009
 

Abstract

1. Hydroxyl radicals (OH) are thought to be generated at sites of inflammation and to contribute to tissue damage. All anti-inflammatory drugs tested were able to scavenge ˙ OH generated in free solution at almost diffusion-controlled rates (rate constants about 1010 M−1 s−1).

2. Much ˙ OH generation in vivo occurs at specific sites, where bound metal ions (such as Fe2+) react with H2O2 to produce ˙ OH that immediately attacks the site. Only ˙ OH scavengers that have sufficient metal-binding ability to withdraw metal ions from this site can protect against site-specific damage.

3. All anti-inflammatory drugs tested were able to protect against site-specific damage by ˙ OH in a simple model system in vitro. Penicillamine, diclofenac sodium, piroxicam, azathioprine, primaquine, chloroquine and hydroxychloroquine were especially effective.

4. The ability of an anti-inflammatory drug to protect against ˙ OH formation in vivo depends not only on its rate constant for reaction with ˙ OH, but also on its metal-binding ability and on the geometry and redox potential of any metal complex formed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.